Report

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Expert Market Research Thumbnail Image

Asia Pacific Drug Development Market: By Mode: In House, Outsourced; By Process Step: Process Research Development, Formulation, Analytical & Stability Studies, Drug Metabolism and Pharmacokinetics (DMPK) Safety Assessment (Toxicology), Regulatory Compliance, Packaging; By Therapeutic Area: Oncology, Inflammation & Immunology, Cardiology, Neuroscience, By Region: India, Japan, China; Competitive Landscape & Supplier Analysis; Events and Developments

Asia Pacific Drug Development Market Key Insights:

 

  • Market Overview
  • Market Opportunities
  • Regional Market Analysis
  • Historical Market Size 2015-2019
  • Competitive Landscape
  • SWOT Analysis
  • Market Forecast 2020-2025
  • Events and Developments
  • Market Indicators

 

Market Outlook 

The Asia Pacific drug development market reached USD 38.23 billion in 2019 and is projected to grow at a CAGR of 7.1% over the 2020-2025 forecast period. The changing market dynamics, such as the constant growth of the pharmerging market, coupled with the saturated growth rates in established markets, are driving the growth of the drug development market in the Asia Pacific. Also, capital inflows from the western region in the Asian pharmaceutical industry offer substantial opportunities for business expansion to new entrants.

Asia Pacific Drug Development Market Report and Forecast 2020-2025

Get a Free Sample Report with Table of Content - Download Now

Properties and Applications
 
Drug development is the method of developing a new drug once a lead compound has been discovered through the drug discovery method. The Asia Pacific drug development industry can be divided on the basis of segments like mode, process step, and therapeutic area.

The industry can be broadly categorised based on mode into:

  • In House
  • Outsourced

The industry can be divided on the basis of process step as:

  • Process Research Development
  • Formulation
  • Analytical and Stability Studies
  • Drug Metabolism and Pharmacokinetics (DMPK)
  • Safety Assessment (Toxicology)
  • Regulatory Compliance
  • Packaging

The industry can be divided based on the therapeutic area:

  • Oncology
  • Inflammation and Immunology
  • Cardiology            
  • Neuroscience
  • Others

The EMR report looks into the Asia Pacific drug development markets like India, Japan, and China.

Market Analysis

Regulatory authorities such as the China Food and Drug Administration have made significant improvements in addressing critical system gaps. These are working to provide the basis for enhancing the registration process and driving developments in the drug development market in the Asia Pacific in order to stimulate growth. In the clinical trials, companies have efficiently shifted from giving a value proposition based on "speed and cost" to value-added proposals. It involves the transition from early-stage licensing to later stage licensing for growth. However, the trend for business model charges, as well as risk-sharing and collaborations, are being adopted. The rise in new product launches depicts the remarkable growth within the Asia Pacific drug development industry. The cost-saving advantages of the Asian market have prompted global companies to integrate Asia into its global framework for drug development. However, to some degree, the existence of some constraints in the area is anticipated to hinder growth. One of these problems is that the study promoters have to pay the cost of studies and research in Asia, whereas insurance providers and government payers in the western countries make payments throughout the trial for the general healthcare costs of enrolled patients. Nevertheless, the average cost of running studies in the Asia Pacific is significantly lower than in the West, thus, reducing the impact of this constraint.

Competitive Landscape
 
The report presents a detailed analysis of the following key players in the Asia Pacific drug development market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Samsung BioLogics 
  • WuXi Biologics 
  • Celltrion Inc. 
  • PT Kalbe Farma Tbk
  • Eurofins Advinus
  • Covance Inc.
  • Celerion Inc.
  • Parexel International Corporation 
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.

Key Questions Answered in the Market Report:

  • How has the Asia Pacific drug development industry performed in the previous years (2015-2019)?
  • What is the forecast assessment of the market for 2020-2025?
  • What are the major drivers of the historical (2015-2019) and forecast (2020-2025) periods?
  • What are the major constraints of the historical (2015-2019) and forecast (2020-2025) periods?
  • What are the major demand indicators of the market?
  • Who are the key manufacturers in the Asia Pacific drug development industry?
  • What is the degree of competition in the market?
  • What are the major events and developments taking place within the industry?

1    Preface
    1.1    Objectives of the Study
        1.1.1    Research Objective
        1.1.2    Key Findings of the Report
2    Research Methodology
    2.1    Data Extraction
    2.2    Data Corroboration
    2.3    Market Structure
    2.4    Assumptions
    2.5    Market Models
3    Introduction
    3.1    Market Outlook
    3.2    Market Scope and Segmentation
    3.3    Additional Insights
4    Executive Summary
    4.1    Key Market Developments
    4.2    Market Analysis
    4.3    Key Players
    4.4    Cost Structure
    4.5    Market Revenue and Growth
5    Market Dynamics
    5.1    Market Driver Analysis
    5.2    Market Restraint Analysis
    5.3    Industry Challenges
    5.4    Industry Opportunities
6    Asia Pacific Drug Development Market Analysis
    6.1    Asia Pacific Drug Development Historical Market (2015-2019) & Forecast (2020-2025)
    6.2    Asia Pacific Drug Development Market Breakup by Mode
        6.2.1    In House
        6.2.2    Outsourced
    6.3     Asia Pacific Drug Development Market Breakup by Mode: Historical Market (2015-2019) & Forecast (2020-2025)
        6.3.1    In House
        6.3.2    Outsourced
    6.4    Asia Pacific Drug Development Market by Process Step
        6.4.1    Process Research Development
        6.4.2    Formulation
        6.4.3    Analytical & Stability Studies
        6.4.4    Drug Metabolism and Pharmacokinetics (DMPK)
        6.4.5    Safety Assessment (Toxicology)
        6.4.6    Regulatory Compliance
        6.4.7    Packaging
    6.5    Asia Pacific Drug Development Market by Process Step: Historical Market (2015-2019) & Forecast (2020-2025)
        6.5.1    Process Research Development
        6.5.2    Formulation
        6.5.3    Analytical & Stability Studies
        6.5.4    Drug Metabolism and Pharmacokinetics (DMPK)
        6.5.5    Safety Assessment (Toxicology)
        6.5.6    Regulatory Compliance
        6.5.7    Packaging
    6.6    Asia Pacific Drug Development Market by Therapeutic Area
        6.6.1    Oncology
        6.6.2    Inflammation & Immunology
        6.6.3    Cardiology             
        6.6.4    Neuroscience
        6.6.5    Others 
    6.7    Asia Pacific Drug Development Market by Therapeutic Area: Historical Market (2015-2019) & Forecast (2020-2025)
        6.7.1    Oncology
        6.7.2    Inflammation & Immunology
        6.7.3    Cardiology             
        6.7.4    Neuroscience
        6.7.5    Others 
    6.8    Asia Pacific Drug Development Market Breakup by Region
        6.8.1    India
        6.8.2    Japan
        6.8.3    China
    6.9    Asia Pacific Drug Development Breakup by Region: Historical Market (2015-2019) & Forecast (2020-2025)
        6.9.1    India
        6.9.2    Japan
        6.9.3    China 
7    SWOT Analysis
    7.1    Overview
    7.2    Strengths
    7.3    Weaknesses
    7.4    Opportunities
    7.5    Threats
8    Porter’s Five Forces Analysis
    8.1    Overview
    8.2    Buyer’s Power
    8.3    Supplier’s Power
    8.4    New Entrants
    8.5    Degree of Rivalry
    8.6    Substitutes
9    Competitive Landscape & Supplier Analysis
    9.1    Samsung BioLogics (207940 (KRX))
        9.1.1    Company Overview
        9.1.2    Financial Analysis
    9.2    WuXi Biologics (2269 (HKG))
        9.2.1    Company Overview
        9.2.2    Financial Analysis
    9.3    Celltrion Inc. (068270 (KRX))
        9.3.1    Company Overview
        9.3.2    Financial Analysis
    9.4    PT Kalbe Farma Tbk
        9.4.1    Company Overview
        9.4.2    Financial Analysis
    9.5    Eurofins Advinus
        9.5.1    Company Overview
        9.5.2    Financial Analysis
    9.6    Covance Inc.
        9.6.1    Company Overview
        9.6.2    Financial Analysis
    9.7    Celerion Inc.
        9.7.1    Company Overview
        9.7.2    Financial Analysis
    9.8    Parexel International Corporation
        9.8.1    Company Overview
        9.8.2    Financial Analysis
    9.9    Others
10    Events and Developments

Introduction

EMR is one of the foremost business intelligence and market research companies with a database of syndicated and customised reports spanning more than 100 industries across global and regional markets. We leverage the knowledge of our highly skilled team of over 100 analysts and more than 3000 independent consultants to provide our clients with thoroughly researched and reliable data tailored to their requirements. We help our clients, who range from Fortune 1000 companies to medium and niche enterprises, make informed strategic decisions through our varied tools and methodology.

Our meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. We understand the distinct nature and requirements for each industry and thus, modify our methodology to best fit the industry in question. Our research methodology uses a combination of cutting-edge analytical tools and the expertise of our highly accomplished team, thus, providing our customers with industry insights that are accurate, actionable, and help them remain ahead of their competition. EMR’ s fine-tuned research methodology and data analysis, formulated through years of cross-industry experience of our team, ensure that our clients are provided with:

  • Value-added and infallible market intelligence.
  • A holistic understanding of the current and expected market fluctuations through meticulously collected data.
  • Verified information on the probable opportunities and risks in the present and forecasted markets.
  • Validated and thoroughly analysed insights derived from our latest analytical tools and impeccable sources.

Assessment Approach

Our approach gives our clients a comprehensive assessment of the prevailing and projected industry conditions through the collection, collation, and analysis of data from trusted sources.

Price Assessment

We assess the historical, prevailing, and expected prices of commodities and raw materials by analysing our assiduously collected data from verified primary and secondary sources. Our assessments reflect the market values of related commodities within a region to help our consumers understand the interdependencies and formulate profitable industry strategies. Our price assessments cover both the average global prices along with the prevailing regional prices.

Market Assessment

Our market assessments determine the global and regional production and consumption of the product, according to their value and volume. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions. We also take into account the demographic, economic, cultural, and political factors that might influence the market.

Data Collection

We gather market intelligence through our extensive database of reliable secondary sources and our exhaustive interviews with multiple industry stakeholders. The information gathered through our primary and secondary sources help us verify and extrapolate data relating to prices, trade, and market fluctuations along with the latest developments in the industry.

Primary Research

As a part of our primary research, we interact with highly placed industrial professionals possessing an expansive and meticulous insight into the market. We conduct our interviews via mails, telephonic conversations, and one-on-one meetings. Thus, our exhaustive interviews with both buyers and consumers help us provide our clients with verified intelligence regarding the market size, share, drivers, prices, and forecast along with a detailed assessment of your supply chain.

Secondary Research

EMR has access to extensive internal and subscribed databases, which apprise us of the historical and prevailing industry conditions and help us forecast the market for the coming few years. Our secondary research involves a wide array of sources ranging from the annual and financial reports of the key players in the industry to governmental and regulatory databases. We refer to various scientific and industry publications and whitepapers to form a comprehensive understanding of the product and the supply chain. Our wide-ranging research also refers to relevant articles and press releases to provide our customers with an up-to-date understanding of the contemporary market. We derive extensive raw data from our secondary research, which then go through a thorough verification and validation process, to help us formulate an exhaustive understanding of the industry, the supply chain, the competitive landscape, and the product.

Other Analyst Tools and Data Models

Our extensive and intricate data models, formulated through our propriety technological and analytical resources, help you easily comprehend the expansive market data and aid you in framing vital business and industry strategies. Our tools provide you with a cohesive understanding of the industry outlook, taking into account the qualitative and quantitative market variables. Our analytical tools and models are regularly updated according to the changes in the continually evolving market scenarios as well as being adapted to best meet our client’s specific needs. Our research methods involve a blend of the best technological tools used in the industry along with the expertise of our analysts and consultants who can spot and assess the implications of the subtle factors influencing the more complex markets.

Data Prioritisation

Our market assessments take into consideration only those data that are confirmed and are derived from credible and transparent sources. Thus, our clients are presented with accurate and infallible data which can be incorporated into their business strategies.

Data Validation

Before our data is presented to the clients, they undergo an intensive cross-verification and validation process. We corroborate the data gathered through our primary and secondary research by the review and validation of the initial sources along with the verification of the data from other thoroughly vetted sources.

Exigent Data Assessment

Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions. By constantly updating our databases and reports to reflect the changes taking place in the industry, our market and price assessments accurately reflect the prevailing industry conditions.

Thus, our rigorous data collection, thorough statistical analysis, and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors, helping them emerge as the undisputed industry leaders in their respective fields.

Purchase Options  

Buy Now  

Call us on

( USA & Canada )
+1-415-325-5166
us.sales@expertmarket
research.com
( United Kingdom )
+44-702-402-5790
uk.sales@expertmarket
research.com
Send Enquiry  

Purchase Full Report

  • Single User License
  • $2999
  • Restricted to one user
  • One print only
  • Available in PDF
  • Free limited customisation (pre sales)
  • Post sales analyst support
  • Free report update (Within 180 Days)
  • Buy Now
  • Five User License
  • $3999
  • Restricted to five users
  • One print per user
  • Available in PDF
  • Free limited customisation (pre sales)
  • Post sales analyst support
  • Free report update (Within 180 Days)
  • Buy Now
  • Corporate License
  • $4999
  • Unlimited users within organisation
  • No limit on prints
  • Available in PPT and PDF
  • Free limited customisation (pre sales)
  • Post sales analyst support
  • Free report update (Within 180 Days)
  • Buy Now

Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports

Expert Market Research Thumbnail Image
United States Medical Cannabis Market Report and Forecast 2020-2025

Cannabis refers to a psychoactive medication extracted from the Cannabaceae family cannabis plant. The drug was used in ancient Indian, Chinese, Egyptian as well as Islamic cultures. These days, canna...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Tumour Necrosis Factor Inhibitor Drugs Market Report and Forecast 2020-2025

The global tumour necrosis factor inhibitor drugs market attained a value of around USD 40.3 billion in 2019. The market is further expected to grow in the forecast period of 2020-2025 at a CAGR of ar...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Uveitis Drugs Market Report and Forecast 2020-2025

The global uveitis drugs market is estimated to grow at a CAGR of almost 6.8% in the forecast period of 2020-2025. The global uveitis drugs market is being driven by the increased prevalence of eye di...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Obsessive-Compulsive Disorder Drugs Market Report and Forecast 2020-2025

The global obsessive-compulsive disorder drugs market is projected to grow at a CAGR of almost 4.8% over the forecast period of 2020-2025. The global obsessive-compulsive disorder drugs market is bein...

  • 24 Hour Email Delivery
  • Price: $ 2999
Expert Market Research Thumbnail Image
Global Sinusitis Drugs Market Report and Forecast 2020-2025

The global sinusitis drugs market is expected to grow in the forecast period of 2020-2025 at a CAGR of more than 5.5%. The prevalence of sinus infection among adults and children is growing. Among the...

  • 24 Hour Email Delivery
  • Price: $ 2999

Stay informed with our free industry updates.

Download Sample

Buy Full Version
"Asia Pacific Drug Development Market" Purchase Enquiry